Specialized to manufacture oral solid dosage forms, Alcami’s Wilmington, North Carolina site supports preclinical production through commercial launch and supply. Our cGMP manufacturing technologies are arranged in flexible suites to support advanced and complex projects.
Alcami will support your animal health products with precise attention to quality by design and process development. We have experience with over 50 animal health products ranging from concept through commercialization in API manufacturing, oral solid dose, and sterile (liquid and lyophilized) products.
Investigational New Drug (IND) Filings
ft² across our facilities
US & EU regulatory filings
CPhI Japan – 3 / 16 - 3 / 18
CED Life Science – 3 / 17 - 3 / 19
DCAT Week – 3 / 23 - 3 / 26
World Orphan Drug Congress – 4 / 29 - 5 / 1